We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
376
Northrop Grumman
NOC
$78B
$9.18M 0.04%
17,386
+1,253
+8% +$614K
IJS icon
377
iShares S&P Small-Cap 600 Value ETF
IJS
$8.2B
$9.17M 0.04%
85,201
-4,860
-5% -$505K
GEV icon
378
GE Vernova
GEV
$251B
$9.17M 0.04%
35,961
-12,928
-26% -$2.48M
HI
379
DELISTED
Hillenbrand
HI
$9.05M 0.04%
325,644
-3,672
-1% -$129K
KMB icon
380
Kimberly-Clark
KMB
$37.5B
$9.04M 0.04%
63,517
+15,693
+33% +$2.23M
KHC icon
381
Kraft Heinz
KHC
$32.4B
$9.03M 0.04%
257,102
+7,761
+3% +$267K
DFS
382
DELISTED
Discover Financial Services
DFS
$8.99M 0.04%
64,078
-462
-0.7% -$62.1K
MO icon
383
Altria Group
MO
$125B
$8.84M 0.04%
173,179
-5,000
-3% -$253K
IWR icon
384
iShares Russell Mid-Cap ETF
IWR
$56.5B
$8.82M 0.04%
100,079
-8,545
-8% -$720K
HDV
385
iShares Core High Dividend ETF
HDV
$14.7B
$8.6M 0.04%
365,420
+16,295
+5% +$373K
LIN icon
386
Linde
LIN
$236B
$8.56M 0.04%
17,942
+180
+1% +$82.1K
SAP icon
387
SAP
SAP
$207B
$8.35M 0.04%
36,438
+3,338
+10% +$710K
NUE icon
388
Nucor
NUE
$60.5B
$8.31M 0.04%
55,288
-535
-1% -$80.5K
GWW icon
389
W.W. Grainger
GWW
$66B
$8.27M 0.04%
7,961
-288
-3% -$279K
COF icon
390
Capital One
COF
$130B
$8.18M 0.04%
54,644
+5,819
+12% +$829K
HUM icon
391
Humana
HUM
$46.7B
$8.15M 0.04%
25,718
+1,813
+8% +$645K
CARR icon
392
Carrier Global
CARR
$52.5B
$8.14M 0.04%
101,070
-6,254
-6% -$435K
ACWI icon
393
iShares MSCI ACWI ETF
ACWI
$32.5B
$8.08M 0.04%
67,581
+89
+0.1% +$10.2K
MPC icon
394
Marathon Petroleum
MPC
$89.3B
$8.04M 0.04%
49,374
-18,346
-27% -$3.1M
WMB icon
395
Williams Companies
WMB
$85.8B
$8M 0.04%
175,294
+1,012
+0.6% +$44.5K
VV icon
396
Vanguard Large-Cap ETF
VV
$52B
$7.78M 0.04%
29,567
-6
-0% -$1.52K
MCO icon
397
Moody's
MCO
$83.9B
$7.71M 0.04%
16,243
-300
-2% -$139K
USFD icon
398
US Foods
USFD
$22.3B
$7.68M 0.04%
124,862
-2,631
-2% -$147K
BNL icon
399
Broadstone Net Lease
BNL
$4.3B
$7.61M 0.04%
401,679
-158,660
-28% -$2.81M
AEP icon
400
American Electric Power
AEP
$72.4B
$7.59M 0.04%
74,008
-3,724
-5% -$363K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.